17th Jan 2006 16:19
GlaxoSmithKline PLC17 January 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 12 January 2006 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 17 January 2006 that following reinvestment of a cash dividend paid to shareholders on 05 January 2006, 662 Ordinary shares in the Company had been purchased on 12 January 2006 for and on behalf of participants in the GlaxoSmithKline Bonus Investment Plan at a price of £14.52 The Trust also notified the Company on 17 January 2006 that 11 Ordinary shares had been transferred from the Trust to a participant in the GlaxoSmithKline Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. One of the Company's directors, Mr J Heslop is thereforeinterested in the shares held in the fund from time to time in the same way asother non US employees or former employees of GlaxoSmithKline plc and itssubsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1 4R (1) (b). S M BicknellCompany Secretary 17 January 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline